Fig. 4From: Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathwayEffects of Cilostazol on TXNIP and NLRP3 expressions in DCM rats were detected by immunohistochemistry (Scar bar: 20 μm). A TXNIP expressions; B NLRP3 expressions. *p < 0.05 vs. Sham group; #p < 0.05 vs. DCM group; &p < 0.05 vs. Cilostazol (15 mg/kg) groupBack to article page